Globe Life Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Globe Life Inc (GL) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Globe Life Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 6,192M vs 1,974,617M combined for tracked competitors (0.3% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+3.3% annualized vs trailing 12 months), vs holding steady (+1.9%) for its tracked peer group.
- Growth: Globe Life Inc generated 8.0% revenue growth year over year in Q2 2026, vs 5.8% for its tracked competitors combined.
- Profitability: Its 18.0% net margin compares with 9.7% for the peer group.
- Scale: Globe Life Inc ranks #8 of 19 companies by market capitalization in the Life Insurance industry, holding 3.6% of industry market cap.
- Peer revenue share: Globe Life Inc accounted for 0.3% of combined revenue among its tracked peer group, up from 0.3% a year earlier.
- Peer differentiation: Revenue per employee of $1.68M compares with $1.46M for the peer group (1.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
GL Sales vs. its Competitors, Q2 2026
Globe Life Inc reported revenue growth of 8.00 % year on year in Q2 2026, above its competitors' combined revenue growth of 5.81 %.
With a net margin of 17.99 %, Globe Life Inc achieved higher profitability than its competitors (9.68 %).
Globe Life Inc generated 0.32 % of the combined sales of its peer group, up from 0.31 % a year earlier.
Globe Life Inc vs. its Competitors, Q2 2026
Revenue growth, year on year
Net income growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Globe Life Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Globe Life Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (8) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Globe Life Inc's competitor groups requires a Commercial License.
For context: the Life Insurance industry grew revenue 5.1% year over year, combined, vs 8.0% for Globe Life Inc. Globe Life Inc's share of combined industry revenue moved from 0.71% to 0.73%, a gain of 0.02 percentage points.
Globe Life Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Globe Life Inc | Yes | Yes | No | No |
| Competitors combined (41) | ||||
| High-Confidence Competitors (1) | ||||
| Similar-Size Competitors (10) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
GL Stock Performance relative to its Competitors
GL Stock Performance relative to High-Confidence Competitors
GL Stock Performance relative to Similar-Size Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Centene Corporation | 282.9% | Outperformed |
| 2 | United Fire Group Inc | 282.9% | Outperformed |
| 3 | Humana Inc | 282.9% | Outperformed |
| 4 | Planet Labs Pbc | 282.9% | Outperformed |
| 5 | Principal Financial Group inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Globe Life Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Globe Life Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Globe Life Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Globe Life Inc | 13,153.37 | 6,191.96 |
| Unitedhealth Group Incorporated | 342,313.98 | 450,129.00 |
| Futu Holdings Ltd | 126,960.16 | 2,935.37 |
| Elevance Health Inc | 85,981.16 | 201,113.00 |
| The Cigna Group | 71,752.79 | 282,382.00 |
| Metlife Inc | 61,985.96 | 79,403.00 |
| SUBTOTAL | 1,303,584.71 | 2,174,679.71 |
Sign in to see all competitors of Globe Life Inc .
Sources: Globe Life Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Globe Life Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Globe Life Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Pldt Inc | Named by the company | 85% |
| Cno Financial Group Inc | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Globe Life Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Globe Life Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Globe Life Inc | Life 54.71 % |
| Unitedhealth Group Incorporated | UnitedHealthcare 76.78 % |
| Elevance Health Inc | Reportable 100.00 % |
| The Cigna Group | Evernorth 85.32 % |
| Metlife Inc | Group Benefits 36.13 % |
| Allstate Corp | Allstate Protection 87.37 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Globe Life Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Globe Life Inc | 13,153 | 1,675,767 | 328,065 |
| Unitedhealth Group Incorporated | 342,314 | 1,154,177 | 38,236 |
| Futu Holdings Ltd | 126,960 | 14,531,554 | 7,188,465 |
| Elevance Health Inc | 85,981 | 2,071,195 | 51,040 |
| The Cigna Group | 71,753 | 4,171,078 | 103,146 |
| Metlife Inc | 61,986 | 1,726,152 | 79,543 |
| PEERS TOTAL | 1,290,431 | 1,460,706 | 113,376 |
Globe Life Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Aon Plc | Europe, Middle East, and Africa, Other Than United Kingdom and Ireland 16.91 % |
| Planet Labs Pbc | North America 42.93 % |
| Blacksky Technology Inc | Non-US 52.87 % |
| Citizens Inc | All Countries 66.88 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Globe Life Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 18 companies in Globe Life Inc's industry classification, broader than the peer set above. Market cap in millions of $.Globe Life Inc ranks #8 of 18 companies by market capitalization in its industry, holding 3.64 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,325, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Manulife Financial Corporation | 85,568 | 23.53 % |
| 2 | Metlife Inc | 62,781 | 17.26 % |
| 3 | Sun Life Financial Inc | 48,173 | 13.25 % |
| 4 | Prudential Financial Inc | 41,246 | 11.34 % |
| 5 | Prudential Plc | 1,234 | 5.2% |
| 6 | Reinsurance Group Of America Incorporated | 1,234 | 5.2% |
| 7 | Corebridge Financial Inc | 1,234 | 5.2% |
| 8 | Globe Life Inc | 13,243 | 3.64 % |
| 9 | Jackson Financial Inc | 1,234 | 5.2% |
| 10 | Voya Financial Inc | 1,234 | 5.2% |
Market cap and industry share for the rest of Globe Life Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
Globe Life Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 3 | Sun Life Financial Inc | 48,173 | 35.67 % |
| 4 | Prudential Financial Inc | 41,246 | 15.46 % |
| 5 | Prudential Plc | 34,680 | -8.28 % |
| 6 | Reinsurance Group Of America Incorporated | 16,452 | 32.43 % |
| 7 | Corebridge Financial Inc | 1,234 | 12.3% |
| 8 | Globe Life Inc | 13,243 | 17.34 % |
| 9 | Jackson Financial Inc | 1,234 | 12.3% |
| 10 | Voya Financial Inc | 1,234 | 12.3% |
| 11 | Primerica Inc | 1,234 | 12.3% |
| 12 | Lincoln National Corporation | 1,234 | 12.3% |
| 13 | Genworth Financial Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Globe Life Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Globe Life Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Life Insurance industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (28 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 57.42 % | 44.67 % (avg) | +12.8 pp |
| Operating Margin | - | industry median | - |
| EBITDA Margin | 36.36 % | 20.82 % (avg) | +15.5 pp |
| Capital Intensity (Capex / Revenue) | 2.57 % | 0.70 % (avg) | +1.9 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Globe Life Inc's Valuation vs Competitive Position
Valuation multiples vs the Life Insurance industry average (28 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | 11.1x | 17.6x | -6.4x |
| EV / EBITDA | 7.0x | 13.8x | -6.8x |
| P/B | 2.2x | 1.2x | +1.1x |
| Return on Equity | 20.28 % | industry aggregate | 9.30 % |
| Return on Invested Capital | - | 5.48 % (avg) | - |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Globe Life Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 11.54 % | 5.39 % | 4.65 % | 7.91 % | 2.00 % | 4.46 % | 6.07 % | 3.74 % |
| Operating Margin | 10.29 % | -22.90 % | -27.19 % | -30.15 % | -12.00 % | -5.49 % | 35.06 % | 36.42 % |
| Return on Invested Capital | 4.81 % | -6.79 % | -7.06 % | -7.80 % | -2.79 % | -0.96 % | 5.97 % | 14.46 % |
| P/E | 10.7x | 15.1x | 13.7x | 13.2x | 15.7x | 11.9x | 9.4x | 9.8x |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Globe Life Inc's BCG Growth-Share Matrix
Relative market share (vs Globe Life Inc's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Globe Life Inc falls in the Dog quadrant: relative market share of 0.15x vs its largest competitor, in an industry growing revenue 7.0% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Globe Life Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 1,325 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 2.57 % vs industry average 0.70 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Globe Life Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Globe Life Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Globe Life Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Globe Life Inc falls in the Medium attractiveness / Medium strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Globe Life Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Return on equity 9.3 points above the industry aggregate.
- Latest-quarter revenue run-rate is accelerating (+3.3% annualized vs trailing 12 months).
- Outperforming the U.S.A. 500 over the trailing 12 months.
Weaknesses
- Low relative market share vs the industry leader (0.15x).
Opportunities
No rule matched.
Threats
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Globe Life Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Globe Life Inc | 0.01 | 0.08 | 0.46 |
| Unitedhealth Group Incorporated | 0.24 | 0.81 | 0.75 |
| Futu Holdings Ltd | 0.06 | 1.19 | 0.30 |
| Elevance Health Inc | 0.22 | 1.50 | 0.72 |
| The Cigna Group | 0.12 | 0.82 | 0.76 |
| Metlife Inc | 0.08 | 0.29 | 0.70 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Globe Life Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Globe Life Inc | Q2 2026 | +8.0 % | +13.8 % |
| Unitedhealth Group Incorporated | Q2 2026 | +0.4 % | +58.7 % |
| Futu Holdings Ltd | Q4 2025 | +67.8 % | +107.6 % |
| Elevance Health Inc | Q2 2026 | +1.4 % | -16.1 % |
| The Cigna Group | Q2 2026 | +6.7 % | +22.4 % |
| Metlife Inc | Q2 2026 | +10.5 % | +6.0 % |
| PEERS TOTAL | +7.1 % | +63.5 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Globe Life Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Globe Life Inc | Q2 2026 | +8.2 % | +27.5 % |
| Unitedhealth Group Incorporated | Q2 2026 | +2.7 % | -9.8 % |
| Futu Holdings Ltd | Q4 2025 | +29.0 % | -67.4 % |
| Elevance Health Inc | Q2 2026 | +3.8 % | +7.5 % |
| The Cigna Group | Q2 2026 | +6.4 % | - |
| Metlife Inc | Q2 2026 | +1,959.3 % | - |
Globe Life Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Globe Life Inc | 3.91% | 12.09% | 20.28% |
| Unitedhealth Group Incorporated | 4.78% | 7.51% | 14.55% |
| Futu Holdings Ltd | 4.95% | 19.69% | 28.25% |
| Elevance Health Inc | 3.99% | 6.09% | 11.19% |
| The Cigna Group | 4.46% | 6.88% | 16.50% |
| Metlife Inc | 0.49% | 0.77% | 12.93% |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Globe Life Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Globe Life Inc | 11.12 | 2.12 |
| Unitedhealth Group Incorporated | 24.31 | 0.76 |
| Futu Holdings Ltd | 87.03 | 43.25 |
| Elevance Health Inc | 17.56 | 0.43 |
| The Cigna Group | 11.27 | 0.25 |
| Metlife Inc | 18.39 | 0.78 |
| PEERS AVERAGE | 7.69 | 0.60 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.